Your browser doesn't support javascript.
loading
An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile.
Sato, Yoshiki; Deguchi, Shoichi; Norose, Tomoko; Oishi, Takuma; Mitsuya, Koichi; Sugino, Takashi; Akiyama, Yasuto; Nagashima, Takeshi; Urakami, Kenichi; Shimoda, Yuji; Ohshima, Keiichi; Hayashi, Nakamasa; Yamaguchi, Ken.
Afiliación
  • Sato Y; Division of Neurosurgery, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Deguchi S; Division of Neurosurgery, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Norose T; Division of Diagnostic Pathology, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Oishi T; Division of Diagnostic Pathology, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Mitsuya K; Division of Neurosurgery, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Sugino T; Division of Diagnostic Pathology, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Akiyama Y; Division of Immunotherapy, Shizuoka Cancer Center, Nagaizumi, Japan.
  • Nagashima T; Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Nagaizumi, Japan.
  • Urakami K; SRL, Tokyo, Japan.
  • Shimoda Y; Medical Genetics Division, Shizuoka Cancer Center Research Institute, Nagaizumi, Japan.
  • Ohshima K; Cancer Diagnostics Research Division, Shizuoka Cancer Center Research Institute, Nagaizumi, Japan.
  • Hayashi N; SRL, Tokyo, Japan.
  • Yamaguchi K; Medical Genetics Division, Shizuoka Cancer Center Research Institute, Nagaizumi, Japan.
Nagoya J Med Sci ; 85(4): 828-835, 2023 Nov.
Article en En | MEDLINE | ID: mdl-38155632
ABSTRACT
Gliosarcoma (GS), a morphological variant of glioblastoma, pathologically shows a biphasic pattern with gliomatous and sarcomatous components. It has been reported that GS has much higher metastatic capacity than glioblastoma. A few reports on the pathology of the extracranial metastasis of GS have shown that metastatic lesions had a sarcomatous component alone or a mixture of gliomatous and sarcomatous ones. Therefore, it is considered that GS tends to disseminate hematogenously due to its mesenchymal sarcomatous component. Herein, we report an autopsy case of GS with multiple extracranial metastases treated by craniotomy, radiotherapy, and bevacizumab. In this case, metastatic lesions at autopsy contained a gliomatous component alone, but no sarcomatous component. In addition, the sarcomatous component disappeared from the intracranial lesion at autopsy after the administration of bevacizumab. In this report, we discuss the clinical course and pathological findings at the initial state, recurrence, and autopsy, including the results of whole-genome analysis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Gliosarcoma / Glioblastoma Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Gliosarcoma / Glioblastoma Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article